A Phase IIa, Multicenter, Double-Blind, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of MK8245 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control.
Phase of Trial: Phase II
Latest Information Update: 23 Dec 2014
At a glance
- Drugs MK 8245 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Mar 2012 Planned number of patients changed from 60 to 76 as reported by European Clinical Trials Database record.
- 03 Jun 2011 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 23 Sep 2009 Planned end date (Sep 2009) added as reported by ClinicalTrials.gov.